ArticleInternational journal of hematology2021

Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience.

Naoko Hosono et al.PubMed ↗Publisher ↗

No numbers read from the abstract.